抗リウマチ薬 Auranofin の抗炎症作用機序の解析
スポンサーリンク
概要
- 論文の詳細を見る
Effects of auranofin, an orally active chrysotherapeutic agent, were examined on the production of prostaglandin E_2(PGE_2) and nitric oxide (NO) in rat peritoneal macrophages and in RAW 264.7 cells, a murine macrophage-like cell line. Auranofin (1-10μM) inhibited PGE_2 production in rat peritoneal macrophages stimulated with 12-O-tetradecanoylphorbol 13-acetate (TPA, 16.2nM) at 8-20 h, but did not affect PGE_2 production at 4 h. However, in non-stimulated rat peritoneal macrophages, auranofin increased PGE_2 production at 4 h and had no effect on PGE_2 production at 8-20 h. It was proved that auranofin (1-10μM) increased COX (cyclooxygenase)-1-dependent PGE_2 production and inhibited COX-2-dependent PGE_2 production in rat peritoneal macrophages. Auranofin showed no effect on the enzyme activities of the purified COX-1 and COX-2 proteins. Furthermore, auranofin did not affect the COX-1 protein level, but inhibited the TPA-induced expression of COX-2 protein. Therefore, it was suggested that auranofin inhibited PGE_2 production by inhibiting the COX-2 protein induction in TPA-stimulated macrophages. In RAW 264.7 cells, auranofin (0.3-3μM) inhibited lipopolysaccharide-induced NO synthesis by inhibiting the induction of NO synthase (NOS) protein expression. Auranofin did not affect the enzyme activity of iNOS (inducible NOS). Finally, using rat peritoneal macrophages, the effects of auranofin on PGE_2 production and NO production were determined. Auranofin (10μM) strongly inhibited the production of PGE_2 and NO, and the induction of COX-2 protein and NOS protein by TPA. Indomethacin, a COX inhibitor, partially inhibited NO production at the concentration at which PGE_2 production was completely inhibited. On the other hand, L-N^G-monomethyl -L-arginine acetate (L-NMMA), a NOS inhibitor, partially inhibited PGE_2 production. NO production was completely inhibited at the same concentration as shown above. These findings suggest that PGE_2 production and NO production partially affect each other. Therefore, the inhibition of PGE_2 production by auranofin might be partly due to the inhibition of NO production, and the inhibition of NO production by auranofin be partly due to the inhibition of PGE_2 production. In conclusion, auranofin inhibits both PGE_2 production and NO production by inhibiting the upregulation of mRNA levels of COX-2 and NOS.
- 公益社団法人日本薬学会の論文
- 2000-03-01
著者
関連論文
- ラットマスト細胞株RBL-2H3においてProstaglandin 産生抑制がLeukotriene産生に与える影響
- 解熱鎮痛薬でアルツハイマー病を予防できるか?
- 抗リウマチ薬 Auranofin の抗炎症作用機序の解析
- 教育ノート 食品安全におけるリスク分析教育に関する考察